Health Catalyst
HCAT
136 hedge funds and large institutions have $132M invested in Health Catalyst in 2025 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 47 reducing their positions, and 29 closing their positions.
1.18% more ownership
Funds ownership: 76.93% → 78.11% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
6% less funds holding
Funds holding: 145 → 136 (-9)
14% less capital invested
Capital invested by funds: $154M → $132M (-$22.3M)
21% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 47
24% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 29
25% less call options, than puts
Call options by funds: $243K | Put options by funds: $323K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$2.17M |
| 2 |
HWM
HighMark Wealth Management
St. Paul,
Minnesota
|
+$1.18M |
| 3 |
NI
Nepsis Inc
Minneapolis,
Minnesota
|
+$1.1M |
| 4 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
+$857K |
| 5 |
PVM
Palogic Value Management
Dallas,
Texas
|
+$487K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
-$2.81M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$1.44M |
| 3 |
Millennium Management
New York
|
-$1.38M |
| 4 |
MCM
Moore Capital Management
New York
|
-$1.14M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$1.06M |
HCAT Hedge Fund Activity: Q4 2025 in Review
136 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q4 2025, worth a combined $132M — down 14% from $154M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of HCAT and 22 opened new positions — a net loss of 7 holders — while 47 trimmed existing stakes and 37 added.
The largest buyer was RA Capital Management, opening a new position worth an estimated $2.17M. The largest seller was Primecap Management, cutting an estimated $2.81M.
- 136 institutional investors held Health Catalyst (HCAT) as of Q4 2025, down from 145 in Q3 2025.
- Funds reported $132M of Health Catalyst stock for Q4 2025, down 14% quarter-over-quarter.
- 22 funds opened new Health Catalyst positions in Q4 2025 and 29 closed out, a net change of -7 holders.
- The largest Health Catalyst buyer in Q4 2025 was RA Capital Management, an estimated $2.17M added.
- The largest Health Catalyst seller in Q4 2025 was Primecap Management, an estimated $2.81M sold.
Based on aggregated 13F filings for Q4 2025.